Collateral for a security interest recorded Feb 24, 2020 (HCR Collateral Management, LLC).
Term ends Sep 16, 2028 · High confidence
20-year base term ended Dec 16, 2024
Held by Nektar Therapeutics
Filed Dec 16, 2004 as application 11/015,196 · Granted Aug 31, 2010
Base term plus 1098 days of patent term adjustment (USPTO delay)
Today
2004
2028
Clock starts
Dec 16, 2004
Dec 16, 2004
Term ends
Sep 16, 2028
Sep 16, 2028
Granted
Aug 31, 2010
Aug 31, 2010
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,098
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
17
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1098 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 16, 2004, when this application, 11/015,196, was filed | Dec 16, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1098 days, USPTO patent term adjustment record | Dec 19, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | +272 days, USPTO 35 U.S.C. 156 certificate | added to Dec 19, 2027: Sep 16, 2028 | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 16, 2028 | High confidence |
This family
| US 7,056,500 | Term ended Jun 2024 | Jun 2024 |
| US 7,786,133 | this patent Sep 2028 | Sep 2028 |
| US 7,662,365 | Term ended Oct 2022 | Oct 2022 |
| Application 11/344,404 | Abandoned not computed | not computed |
| Application PCT/US2007/009761 | PCT application no patent term | no patent term |
| US 8,183,376 | In force Nov 2028 | Nov 2028 |
| US 8,349,307 | Term ended Oct 2022 | Oct 2022 |
| US 8,067,431 | Term ended Feb 2025 | Feb 2025 |
8 of 17 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 5, 2006 Reel 18607, frame 341 | Bentley, Michael D.; Viegas, Tacey X.; Goodin, Richard R.; Zhao, Xuan; Cheng, Lin | Nektar Therapeutics Al, Corporation | Assignment of Assignor's Interest |
| Aug 31, 2009 Reel 23196, frame 394 | Nektar Therapeutics Al, Corporation | Nektar Therapeutics | Merger |
| Jul 17, 2012 Reel 28571, frame 141 | Nektar Therapeutics | Wells Fargo Bank, National Association, as Collateral Agent | Grant of Security Interest |
| Mar 11, 2013 Reel 29964, frame 920 | Wells Fargo Bank, National Association, as Collateral Agent | Nektar Therapeutics | Partial Release of Patents |
| Oct 6, 2015 Reel 36796, frame 562 | Nektar Therapeutics | TC Lending, LLC, as Collateral Agent | Grant of Security Interest in United States Patents |
| Oct 14, 2015 Reel 36866, frame 700 | Wells Fargo Bank, National Association, as Collateral Agent | Nektar Therapeutics | Release of Security Interest Recorded at Reel 28571, Frame 0141 |
| Feb 24, 2020 Reel 51909, frame 460 | Redhill Biopharma Inc. | HCR Collateral Management, LLC, as Administrative Agent | Security Interest |
| Apr 17, 2020 Reel 53180, frame 9 | TC Lending, LLC, as Collateral Agent | Nektar Therapeutics | Release of Security Interest |
| Jul 10, 2024 Reel 67953, frame 105 | HCR Collateral Management, LLC, as Administrative Agent | HCR Redhill SPV, LLC, as Successor Administrative Agent | Security Interest |
| Jul 19, 2024 Reel 68034, frame 458 | HCR Redhill SPV, LLC | Redhill Biopharma Inc.; Redhill Biopharma Ltd. | Release of Security Interest |
| Jul 19, 2024 reel/frame not recorded | HCR Redhill SPV, LLC | Redhill Biopharma Inc. | Release of Security Interest |
| Jul 19, 2024 reel/frame not recorded | HCR Redhill SPV, LLC | Redhill Biopharma Ltd. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Sep 2028
Term ends Sep 16, 2028. No further fees fall due before then
Note
The 1098 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
122
later US patents cite this one
That is top 5% of utility patents granted in 2010 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.